Bill

Bill > LB195


NE LB195

Provide immunity for administration of naloxone, nalmefene, or other federally approved opioid overdose reversal medications


summary

Introduced
01/14/2025
In Committee
01/16/2025
Crossed Over
02/26/2025
Passed
04/03/2025
Dead
Signed/Enacted/Adopted
04/08/2025

Introduced Session

109th Legislature

Bill Summary

A BILL FOR AN ACT relating to the Uniform Controlled Substances Act; to amend section 28-470, Revised Statutes Cumulative Supplement, 2024; to provide for immunity for conduct relating to opioid overdose reversal medications; to provide and eliminate definitions; and to repeal the original section.

AI Summary

This bill expands legal protections for individuals and professionals who obtain and administer opioid overdose reversal medications like naloxone and nalmefene during potential overdose situations. The legislation provides immunity from criminal prosecution, administrative action, and civil liability for health professionals, family members, friends, school personnel, emergency responders, and law enforcement personnel who obtain and administer these medications in good faith. The bill broadens the definition of "opioid overdose reversal medication" to include any FDA-approved lifesaving medication for reversing opioid overdoses, whether obtained by prescription, from a health professional, or over the counter. This means that more people can legally help someone experiencing an opioid overdose without fear of legal consequences, as long as they act reasonably and in good faith. The bill aims to increase access to and use of overdose reversal medications, which can be critical in saving lives during an opioid overdose emergency, by removing potential legal barriers that might discourage people from providing immediate assistance.

Committee Categories

Justice

Sponsors (1)

Last Action

Approved by Governor on April 7, 2025 (on 04/08/2025)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...